203 related articles for article (PubMed ID: 14747299)
1. Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca2+-ATPase.
Bidasee KR; Zhang Y; Shao CH; Wang M; Patel KP; Dincer UD; Besch HR
Diabetes; 2004 Feb; 53(2):463-73. PubMed ID: 14747299
[TBL] [Abstract][Full Text] [Related]
2. Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels.
Bidasee KR; Nallani K; Yu Y; Cocklin RR; Zhang Y; Wang M; Dincer UD; Besch HR
Diabetes; 2003 Jul; 52(7):1825-36. PubMed ID: 12829653
[TBL] [Abstract][Full Text] [Related]
3. Cardiac-specific overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a) activity and impairs cardiac function in mice.
Asahi M; Otsu K; Nakayama H; Hikoso S; Takeda T; Gramolini AO; Trivieri MG; Oudit GY; Morita T; Kusakari Y; Hirano S; Hongo K; Hirotani S; Yamaguchi O; Peterson A; Backx PH; Kurihara S; Hori M; MacLennan DH
Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9199-204. PubMed ID: 15201433
[TBL] [Abstract][Full Text] [Related]
4. Replacement of the muscle-specific sarcoplasmic reticulum Ca(2+)-ATPase isoform SERCA2a by the nonmuscle SERCA2b homologue causes mild concentric hypertrophy and impairs contraction-relaxation of the heart.
Ver Heyen M; Heymans S; Antoons G; Reed T; Periasamy M; Awede B; Lebacq J; Vangheluwe P; Dewerchin M; Collen D; Sipido K; Carmeliet P; Wuytack F
Circ Res; 2001 Oct; 89(9):838-46. PubMed ID: 11679415
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy.
Trost SU; Belke DD; Bluhm WF; Meyer M; Swanson E; Dillmann WH
Diabetes; 2002 Apr; 51(4):1166-71. PubMed ID: 11916940
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Advanced Glycation End Products Formation Attenuates Cardiac Electrical and Mechanical Remodeling and Vulnerability to Tachyarrhythmias in Diabetic Rats.
Chang GJ; Yeh YH; Chen WJ; Ko YS; Pang JS; Lee HY
J Pharmacol Exp Ther; 2019 Jan; 368(1):66-78. PubMed ID: 30381326
[TBL] [Abstract][Full Text] [Related]
7. Decreased cardiac sarcoplasmic reticulum Ca2+ -ATPase activity contributes to cardiac dysfunction in streptozotocin-induced diabetic rats.
Zhao XY; Hu SJ; Li J; Mou Y; Chen BP; Xia Q
J Physiol Biochem; 2006 Mar; 62(1):1-8. PubMed ID: 16909926
[TBL] [Abstract][Full Text] [Related]
8. Gender differences in myosin heavy chain-beta and phosphorylated phospholamban in diabetic rat hearts.
Zhong Y; Reiser PJ; Matlib MA
Am J Physiol Heart Circ Physiol; 2003 Dec; 285(6):H2688-93. PubMed ID: 12933346
[TBL] [Abstract][Full Text] [Related]
9. Carbonylation contributes to SERCA2a activity loss and diastolic dysfunction in a rat model of type 1 diabetes.
Shao CH; Capek HL; Patel KP; Wang M; Tang K; DeSouza C; Nagai R; Mayhan W; Periasamy M; Bidasee KR
Diabetes; 2011 Mar; 60(3):947-59. PubMed ID: 21300842
[TBL] [Abstract][Full Text] [Related]
10. Improvement of defective sarcoplasmic reticulum Ca2+ transport in diabetic heart of transgenic rats expressing the human kallikrein-1 gene.
Tschöpe C; Spillmann F; Rehfeld U; Koch M; Westermann D; Altmann C; Dendorfer A; Walther T; Bader M; Paul M; Schultheiss HP; Vetter R
FASEB J; 2004 Dec; 18(15):1967-9. PubMed ID: 15448111
[TBL] [Abstract][Full Text] [Related]
11. Transgenic overexpression of the sarcoplasmic reticulum Ca2+ATPase improves reticular Ca2+ handling in normal and diabetic rat hearts.
Vetter R; Rehfeld U; Reissfelder C; Weiss W; Wagner KD; Günther J; Hammes A; Tschöpe C; Dillmann W; Paul M
FASEB J; 2002 Oct; 16(12):1657-9. PubMed ID: 12206992
[TBL] [Abstract][Full Text] [Related]
12. Altered SR protein expression associated with contractile dysfunction in diabetic rat hearts.
Zhong Y; Ahmed S; Grupp IL; Matlib MA
Am J Physiol Heart Circ Physiol; 2001 Sep; 281(3):H1137-47. PubMed ID: 11514280
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress in cardiomyocytes contributes to decreased SERCA2a activity in rats with metabolic syndrome.
Balderas-Villalobos J; Molina-Muñoz T; Mailloux-Salinas P; Bravo G; Carvajal K; Gómez-Viquez NL
Am J Physiol Heart Circ Physiol; 2013 Nov; 305(9):H1344-53. PubMed ID: 23997093
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation and binding of AUF1 to the 3'-untranslated region of cardiomyocyte SERCA2a mRNA.
Blum JL; Samarel AM; Mestril R
Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2543-50. PubMed ID: 16113063
[TBL] [Abstract][Full Text] [Related]
15. Conditional increase in SERCA2a protein is able to reverse contractile dysfunction and abnormal calcium flux in established diabetic cardiomyopathy.
Suarez J; Scott B; Dillmann WH
Am J Physiol Regul Integr Comp Physiol; 2008 Nov; 295(5):R1439-45. PubMed ID: 18799637
[TBL] [Abstract][Full Text] [Related]
16. Peptidyl-Prolyl Isomerase 1 Regulates Ca
Sacchi V; Wang BJ; Kubli D; Martinez AS; Jin JK; Alvarez R; Hariharan N; Glembotski C; Uchida T; Malter JS; Yang Y; Gross P; Zhang C; Houser S; Rota M; Sussman MA
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29018025
[TBL] [Abstract][Full Text] [Related]
17. Malondialdehyde and 4-hydroxynonenal adducts are not formed on cardiac ryanodine receptor (RyR2) and sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2) in diabetes.
Moore CJ; Shao CH; Nagai R; Kutty S; Singh J; Bidasee KR
Mol Cell Biochem; 2013 Apr; 376(1-2):121-35. PubMed ID: 23354458
[TBL] [Abstract][Full Text] [Related]
18. Depressed levels of Ca2+-cycling proteins may underlie sarcoplasmic reticulum dysfunction in the diabetic heart.
Netticadan T; Temsah RM; Kent A; Elimban V; Dhalla NS
Diabetes; 2001 Sep; 50(9):2133-8. PubMed ID: 11522681
[TBL] [Abstract][Full Text] [Related]
19. Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene.
Periasamy M; Reed TD; Liu LH; Ji Y; Loukianov E; Paul RJ; Nieman ML; Riddle T; Duffy JJ; Doetschman T; Lorenz JN; Shull GE
J Biol Chem; 1999 Jan; 274(4):2556-62. PubMed ID: 9891028
[TBL] [Abstract][Full Text] [Related]
20. Doxycycline inducible expression of SERCA2a improves calcium handling and reverts cardiac dysfunction in pressure overload-induced cardiac hypertrophy.
Suarez J; Gloss B; Belke DD; Hu Y; Scott B; Dieterle T; Kim YK; Valencik ML; McDonald JA; Dillmann WH
Am J Physiol Heart Circ Physiol; 2004 Nov; 287(5):H2164-72. PubMed ID: 15256372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
